Concepedia

Yüksel Filik

YF

Statistics

Publications

5

Citations

129

H-Index

5

Active since

2016

Affiliations

Medical University of Vienna(Current)

Ludwig Boltzmann Institute for Cancer Research

University of Veterinary Medicine Vienna

Yüksel Filik is an author at Medical University of Vienna specializing in molecular oncology, medicine, and oncology.

Publications per year

2016–2024

5

Publications

5

Asciminib and ponatinib exert synergistic anti-neoplastic effects on CML cells expressing <i>BCR-ABL1</i> <sup>T315I</sup>-compound mutations.

Karoline V. Gleixner, Yüksel Filik, Daniela Berger et al. · PubMed · 2021 · 41 citations · Full text

Medicine, Oncology, Pharmacology +13

The unfolded protein response impacts melanoma progression by enhancing FGF expression and can be antagonized by a chemical chaperone

Karin Eigner, Yüksel Filik, Florian Mark et al. · Scientific Reports · 2017 · 37 citations · Full text

Medicine, Molecular Biology, Oncology +17

<scp>BRD4</scp> degraders may effectively counteract therapeutic resistance of leukemic stem cells in <scp>AML</scp> and <scp>ALL</scp>

Karin Bauer, Alexander W. Hauswirth, Karoline V. Gleixner et al. · American Journal of Hematology · 2024 · 21 citations · Full text

Medicine, Molecular Biology, Oncology +15

STAT5 is Expressed in CD34+/CD38− Stem Cells and Serves as a Potential Molecular Target in Ph-Negative Myeloproliferative Neoplasms

Emir Hadzijusufovic, Alexandra Keller, Daniela Berger et al. · Cancers · 2020 · 16 citations · Full text

Medicine, Cell Biology, Hematology +15

The unfolded protein response is a negative regulator of scavenger receptor class B, type I (SR-BI) expression

Tanja Eberhart, Karin Eigner, Yüksel Filik et al. · Biochemical and Biophysical Research Communications · 2016 · 14 citations · Full text

Life Sciences, Biochemistry, Molecular Biology +17

1–5 of 5